-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/breast-cancer-medications_appendixes.pdf
March 01, 2009 - $ or tumor$ or malignan$ or carcino$ or neoplas$)).mp. … /ep, et
8 4 and 7
9 exp Breast Neoplasms/pc, eh
10 exp Breast Neoplasms/ge
A1-6
11 4 and … in situ: data from the
Connecticut Tumor Registry. … Re: second cancers after adjuvant tamoxifen therapy for breast cancer. … EPC GRADE Criteria for Assigning
Strength of Evidence*
Grade Definition
High High confidence that
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/grades-predictive-values_white-paper-2015.pdf
January 01, 2015 - pelvic lymphadenectomy
for the prevention of lymphocyst
formation in patients with gynaecological
malignancies … Hahn D, Cody June D, Hodson Elisabeth
M. … Horey D, Kealy M, Davey M-A, et al. … Kumar P, Chawla D, Deorari A. … Trastuzumab containing regimens for
early breast cancer.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/breast-biopsy-executive.pdf
December 01, 2009 - Layout 1
Background
Breast cancer is the second most common
malignancy of women, with over 180,000 … However, it is generally acknowledged
that early diagnosis and treatment of breast tumors
leads to improved … The grade was developed after
consideration of the quality of the evidence base, the
size of the evidence … Summary of key accuracy findings (Key Question 1)
Number of Number of
Number of malignancies invasive … missed Risk of expected per cancers
cancers malignancy 1,000 biopsy expected per Strength of
expected
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/liver-cancer_research-protocol.pdf
July 24, 2013 - d. … d. … d. … Liver Neoplasms/
3. ("hepatocellular cancer" or "hepatocellular carcinoma" or "HCC").ti,ab.
4. … D.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-tests-grading_methods.pdf
July 01, 2012 - with a BI-RADS® 4 score following mammography and expected to have an approximate prebiopsy risk of
malignancy … Owens DK, Lohr KN, Atkins D, et al. … Atkins D, Fink K, Slutsky J. … Samson D, Schoelles KM. … Impact of Gene Expression Profiling
Tests on Breast Cancer Outcomes.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/evidence-examples_white-paper.pdf
April 01, 2014 - In childhood cancer survivors, a linear dose-response relationship was
observed between primary neoplasms … Norris S, Atkins D, Bruening W, et al. … Chou R, Aronson N, Atkins D, et al. … Norris SL, Moher D, Reeves BC, et al. … New
primary neoplasms of the central nervous system
in survivors of childhood cancer: a report from
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/prostate-cancer-therapies-update_disposition-comments.pdf
December 16, 2014 - grade of the tumor
ES-3
“The key finding of the analysis was that the Prostate Cancer Intervention … may sometimes underestimate the
true Gleason grade of the tumor.” … ,
Reduces the risk of a second malignant neoplasms (SMN) in prostate
patients compared with contemporary … Keizman D, Zahurak M, Sinibaldi V, et al. … Risk
of secondary malignant neoplasms from
proton therapy and intensity-modulated x-
ray therapy for
-
effectivehealthcare.ahrq.gov/sites/default/files/renal-cancer_disposition-comments.pdf
February 24, 2016 - d. … The main
point is that larger tumors are associated with
malignancy, and that the OR of 1.3 gives a … What was the denominator for assessing the diagnostic accuracy
of determining tumor grade. specifically … Then, among patients with surgical
pathology available, we compared final tumor
grade to biopsy grade … Please see Michael D.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/rtc-design-principles_research.pdf
January 01, 2009 - and high-grade lesions detected, but one test
might detect a higher proportion of high-grade cytological … tumor foci in women with a
diagnosis of early breast cancer on mammography and ultrasonography planned … mastectomy provides the same relative effects for patients detected by either
test, the number of tumor … needle biopsy to detect false positive
MRI results, some women with a positive MRI finding of multiple tumor … Results of conservative surgery
and radiation therapy for multiple
synchronous cancers of one breast
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/vitamin-d-calcium_research-protocol.pdf
September 13, 2013 - (incident or mortality)
Total cancer
Prostate cancer
Colorectal cancer
Breast cancer
… BMD, BMC25(OH)D;
1,25(OH)2D
Calcium
balance
Bone health
CVD
Cancer
Muscle
function
Cancer markers … cancer, and cancer-specific mortality … Several additional criteria
will be considered in assigning a ROB grade. … If
desired, we will grade the SOE, based on the AHRQ Methods Guide (chapter 1011).
-
effectivehealthcare.ahrq.gov/products/vitamin-d-calcium/research-protocol
June 10, 2013 - (incident or mortality)
Total cancer
Prostate cancer
Colorectal cancer
Breast cancer
Pancreatic … People with previous cancer (or cancer survivors), previous fractures, and precancerous conditions (e.g … cancer, and cancer-specific mortality. … Several additional criteria will be considered in assigning a ROB grade. … If desired, we will grade the SOE, based on the AHRQ Methods Guide (chapter 10 11 ).
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/prioritization-selection-of-harms.pdf
February 01, 2018 - Chou R, Aronson N, Atkins D, et al. … Chou R, Aronson N, Atkins D, et al. … D-1
Appendix D. Key Informant Interview Themes
1. … D-2
• Sometimes consider composite safety AE. … for NIMI Bladder
Cancer?
-
effectivehealthcare.ahrq.gov/products/breast-biopsy-update/research-protocol
September 20, 2013 - is the second most common malignancy (after skin cancer), and the second most common cause of cancer … D. … Morrison A, Polisena J, Husereau D, et al. … Wells G, Shea B, O'Connell D, et al. … /di or exp breast neoplasms/di or exp breast disease/di or exp breast diseases/di
4
(breast or
-
effectivehealthcare.ahrq.gov/sites/default/files/moyer_eccs2012.pdf
January 01, 2012 - Controversy
“Those PSA
[prostate-‐specific
antigen]
blood
tests
that check for prostate
cancer … do
more harm
than good and healthy men should no longer receive them
as part of
routine cancer … Moderate B B C D
Low Insufficient (I Statement)
Slide 6: U.S. … Preventive Services
Task Force Recommendation Grades
Grade Definition
A The U.S. … D The USPSTF recommends against the service.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/colorectal-cancer-screening_executive.pdf
February 01, 2012 - Adenoma—Benign tumor from epithelial tissue. … adenomas—Adenomas 1 cm or greater, or with
villous components (tubulovillous or villous), or with
high-grade … Stool DNA and occult
blood testing for screen detection of colorectal neoplasia. … Detection of stool DNA
mutations before and after treatment of colorectal neoplasia. … Stool methylation-specific
polymerase chain reaction assay for the detection of
colorectal neoplasia
-
effectivehealthcare.ahrq.gov/products/cystic-fibrosis-hgh/research-protocol
January 22, 2010 - KQ 5: What is the risk of malignancy associated with rhGH use as determined by: (a) markers of cancer … D. … Schnabel D, et al. … Hardin D. … Follman D, Elliot P, Suh I, Cutler J.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/colorectal-cancer-staging_disposition-comments.pdf
November 20, 2014 - well as on tumor size and extent, while
for rectal cancer imaging of distant metastases is not as important … as is gauging tumor depth and local spread.” … Also “not statistically significant”
should not be a reason for the grade to be “insufficient”. … For preoperative rectal cancer T (tumor) staging, ERUS is less
likely than CT to incorrectly stage ( … d.
-
effectivehealthcare.ahrq.gov/products/cancer-decision-support-tools/research-protocol
November 12, 2013 - For example, choosing to remove or destroy a low-grade prostatic malignancy can lead to complications … D. … Saslow D, Solomon D, Lawson HW, et al. … "[Mesh] OR cancer OR cancers OR neoplasm* OR malignan* OR premalignan* OR precancerous OR hypertrophy … "[Mesh] OR cancer OR cancers OR neoplasm* OR malignan* OR premalignan* OR precancerous))
Filters:Publication
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-grading-evidence_methods.pdf
November 01, 2013 - Atkins D, Fink K, Slutsky J. … Owens DK, Lohr KN, Atkins D, et al. … Atkins D, Best D, Briss PA, et al. Grading
quality of evidence and strength of
recommendations. … the data published in
observational studies of the association
between diet and prostate or bladder cancer … Sterne JA, Gavaghan D, Egger M.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/cystic-fibrosis-hgh_research-protocol.pdf
August 22, 2008 - KQ 5: What is the risk of malignancy associated with rhGH use as determined by: a)
markers of cancer … D. … Schnabel D, Grasemann C, Stabb D, et al. … Hardin DS, Adams-Huet B, Brown D, et al. … FollmanN D, ElliotT P, Suh I, et al.